Amino acid replacement: S77F.
C8689750T
S77F | Ppt1-PA; S77F | Ppt1-PB
S77F
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
In humans, Batten disease is characterised by the accumulate abnormal storage material in irregular granular deposits (GRODs) and autofluorescent inclusions in the brain, and the progressive death of neurons in the CNS. The Ppt1S77F, and Ppt1S77F/Ppt1A179T flies show abnormal storage material in highly laminar spherical deposits and increased autofluorescent inclusions. No neurodegeneration detected.
short lived (with Ppt1A179T)
The brains of Ppt1S77F mutant flies exhibit increased levels of autofluorescent compared to controls. No difference in the levels of autofluorescent deposits is seen in stage 8-17 embryos.
Ppt1S77F mutant embryos display an abnormal complement of eve-positive neural precursors and neurons at stage 11/12. Many hemisegments exhibit a variety of phenotypes including the loss of GMC4.2a, extra RP2/sib neurons, disorganised eve+ clusters, and extra aCC/pCC cells. Later in development at stages 14-15 loss of eve+ RP2s is observed in a small, but significant, percentage of hemisegments.
Ppt1S77F mutant stage 17 embryos show mild to severe CNS axon guidance defects; defects range from mild phenotypes such as irregularly spaced axon tracts in commissures and wavy, thinning longitudinal connectives, to more severe phenotypes such as fused commissures and disorganized CNS tracts. At stage 17 disruption is seen to the Fas2-positive longitudinal connectives. Phenotypes vary in severity ranging from loose and defasiculated connectives to ectopic midline crossing.
Chordotonal neurons (lch5) in the developing PNS are abnormal in many Ppt1S77F mutant stage 17 embryos. Defects include a decreased number of sensory neurons, fused and abnormally shaped neurons, organisational and positional defects and thin axon bundles. No detectable difference is seen in the axon projections in the l, v and v' neuron clusters.
Ppt1A179T/Ppt1S77F mutant embryos display an abnormal complement of eve-positive neural precursors and neurons at stage 11/12. Many hemisegments exhibit a variety of phenotypes including the loss of GMC4.2a, extra RP2/sib neurons, disorganised eve+ clusters, and extra aCC/pCC cells. Later in development at stages 14-16 loss of eve+ RP2s is observed in a small, but significant, percentage of hemisegments.
At stages 14-15, Ppt1S77F/Df(1)446-20 mutant embryos exhibit loss of eve+ RP2s is observed in a small, but significant, percentage of hemisegments.
Ppt1S77F/Df(1)446-20 and Ppt1A179T/Ppt1S77F flies accumulate abnormal storage material as laminar deposits in their brains.
Ppt1S77F/Df(1)446-20 and Ppt1A179T/Ppt1S77F flies have more abundant autofluorescent inclusions in the brain than control flies.
The median lifespan of Ppt1S77F/Df(1)446-20 and Ppt1A179T/Ppt1S77F flies is reduced 42 and 20% respectively compared to controls.
The median lifespan of Ppt1S77F hemizygotes is reduced 29% compared to controls.